Openbookopenbook
Equity
Solesence, Inc. Common Stock(SLSN)
USD --+0.00%
Reward58Moderate
Risk56Medium-High
📊75%Data
Thin 2% profit margin · Revenue down 14% YoY
SLSN
+0.0 · +0.00%
USD · NASDAQ
Solesence, Inc. Common Stock | Consumer Defensive
Profitless Growth
Market Cap:90.29M
ℹ️
Reward Rating
58
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
56
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on SLSN to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Solesence, Inc. Common Stock?

, a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States.

SLSN · Verdict

Solid reward · elevated risk

SLSN's standout is growth; profitability and valuation weigh on the picture.

Based on 88% data coverage

SLSN · Verdict

What’s working & what to watch

Strengths 1

  • Growth90/100

    Rev +21.1% CAGR · earnings +22.2%

Watchouts 2

  • Profitability27/100

    8% net margin · 7% ROE

  • Valuation28/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Solesence, Inc. Common Stock?

, a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States. The company engages in engineered materials, formulation development, and commercial manufacturing. The company is listed on the NASDAQ in USA, operating in the Consumer Defensive sector, with a market capitalisation of 90.29M, and a P/E ratio of 128.0x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (58)

The scoring profile indicates moderate reward potential, with growth and momentum as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorConsumer Defensive
Market Cap90.29M
P/E Ratio128
Dividend YieldN/A
52 Week High5.63
52 Week Low1.16
Last AnnualDecember
IPO Date3/20/2012
IncorporatedUSA
Shares Outstanding71M
No. of Employees98
IndustryHousehold & Personal Products
ExchangeNASDAQ
Beta1.091
CurrencyUSD
Websitesolesence.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.